Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on Lynch syndrome

H T Lynch1, T Smyrk

  • 1Department of Preventive Medicine, Creighton University School of Medicine, Omaha, NE 68178, USA.

Current Opinion in Oncology
|August 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Southwestern Athabaskan genetic diseases.

Genetics in medicine : official journal of the American College of Medical Genetics·2001
Same author

Family information service and hereditary cancer.

Cancer·2001
Same author

Current status of prophylactic surgery for hereditary breast and gynecologic cancers.

Current opinion in obstetrics & gynecology·2001
Same author

Parental communication of BRCA1/2 genetic test results to children.

Patient education and counseling·2001
Same author

Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families.

Gastroenterology·2000
Same author

E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma.

Cancer genetics and cytogenetics·2000
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Advances in hereditary nonpolyposis colorectal cancer (HNPCC) research focus on DNA mismatch repair gene mutations. Studies now define testing criteria, link genotype to extracolonic tumor risk, and explore management strategies for carriers.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Hereditary nonpolyposis colorectal cancer (HNPCC) is linked to germline mutations in DNA mismatch repair genes.
  • Understanding these mutations is key to diagnosing and managing HNPCC.

Purpose of the Study:

  • To review recent advances in HNPCC research.
  • To summarize findings on mutation prevalence, genotype-phenotype correlations, and carcinogenic mechanisms.
  • To discuss management strategies for HNPCC patients and carriers.

Main Methods:

  • Literature review of recent studies on HNPCC.
  • Analysis of data on germline mutation prevalence and testing criteria.
  • Examination of genotype-phenotype relationships and extracolonic tumor development.

Related Experiment Videos

  • Review of research on HNPCC carcinogenesis and management.

    • Main Results:

    • Prevalence studies have helped define criteria for genetic testing in at-risk individuals.
    • Emerging evidence links specific mutations to a wider range of extracolonic tumors.
    • Carcinogenetic mechanisms in HNPCC differ from sporadic colorectal cancer with microsatellite instability.
    • Research is clarifying the management of HNPCC germline carriers and affected individuals.

    Conclusions:

    • Recent advances have significantly improved the understanding of HNPCC's molecular basis and clinical implications.
    • Continued research is crucial for refining diagnostic, prognostic, and therapeutic approaches.
    • Personalized management strategies based on genetic profiles are becoming increasingly important.